// App-Quantinova.ai

e15608 : Body composition and association with treatment toxicity in patients with advanced renal cell carcinoma receiving targeted agents.

Researchers

Presenter

  • Kelly McCabe

Principal Investigators

  • Vicky Goh

  • Anup Vinayan

  • Ann Petruckevitch

  • Paul D. Nathan

Medical Centers

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom

  • Mount Vernon Cancer Centre, Northwood, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Metastatic Renal Cell Cancer

  • Sarcopenia

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Serine/threonine-protein kinase mTOR

  • Vascular endothelial growth factor A

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved